Skip to main content

Axogen Inc

For the period ended Dec 31, 2023. Filed Mar 5, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 5, 2024

AXGN$50.64+1.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Properties

Our material physical properties consisted of the following as of December 31, 2023
LocationGeneral CharacterTotal Square FeetSquare Feet UtilizedExpiration
Alachua, Florida (1)Headquarters - General office, warehousing and distribution19,00019,00010/31/2026
Tampa, Florida (1)Headquarters - General office, medical laboratory, and meeting space75,00062,50010/31/2034
Burleson, Texas (1)Facility - Raw material and finished goods warehousing and distribution15,00015,0004/30/2027
10,0005,0009/30/2027
Vandalia, Ohio (2)Facility - Clean-room, manufacturing, warehousing, and office space.107,00082,500N/A
Dayton, Ohio (3)(4)Facility - Clean-room/manufacturing, warehousing, and office spaceVariesVaries12/31/2026
(1)Property is encumbered by a lease agreement and is collateral to our Credit Facility.
(2)Property is collateral to our Credit Facility.
(3)Property is encumbered by our CTS Agreement as an embedded lease.
(4)Total square feet and utilization varies each month for the use of CTS's clean room/manufacturing, warehousing, and office space in accordance with the CTS Agreement.

We believe that our facilities will be sufficient to operate our business for the next 12 months and that current lease obligations will not change materially.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.